|
14th ISCB INTERNATIONAL CONFERENCE (1SCBC-2010)
CHEMICAL BIOLOGY FOR DISCOVERY; PERSPECTIVES AND CHALLENGES
January 15 – 18, 2010
SCIENTIFIC PROGRAM
Friday, January 15-01-2010
9.30 AM -2.30 PM |
Registration |
2.30 PM-3.20 PM |
Inaugural Session |
Welcome Address: |
Dr. Tushar Kanti Chakraborty, Director, CDRI |
Introduction to ISCB: |
Dr. P.M.S. Chauhan, Secretary, ISCB. |
Presidential Address: |
Prof. D.P. Singh, Vice chancellor , BHU, Varanasi |
Address by Chief guest |
Prof. David St. C. Black, Secretary General ,IUPAC
University of New South Wales , Sydney, Australia |
Vote of Thanks: |
Dr. P.M.S. Chauhan, Secretary, ISCB |
3.20 PM-4.00 PM |
High-Tea |
Session – I
Chairpersons: Prof. Vadim T. Ivanov and Prof. Cynthia J. Burrows
PL-1
4.00 PM-4.40 PM |
Colin J. Suckling, University of Strathclyde, Glasgow, Scotland,UK
Heterocyclic chemistry at the edge of biology and medicine |
PL-2
4.40 PM-5.40 PM |
Michael D. Threadgill, University of Bath, Claverton UK
Nad+-Requiring Enzymes As Targets For Medicinal Chemistry |
5.40 PM-6.30 PM |
ISCB Award Lectures-1 & 2 |
6.30 PM – 7.30 PM Poster Session -1 (Poster Numbers 1-80)
7.30 PM – 8.30 PM Cultural Programme
8.30 PM Dinner
Saturday, January 16-01-2010
SESSION – II: Chairpersons: Prof. Colin J. Suckling and Prof Michael D. Threadgill
PL-3,
9.00 AM-9.40 AM |
V.T. Ivanov ,Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia
Challenges and practical perspectives of peptidomic research |
PL-4
9.40 AM-10.20 AM |
Tsann-Long Su,Institute of Biomedical Sciences, Academia Sinica, Taipei ,Taiwan.
Oncologic Drug Development: From Target Identification to Bedside |
IL-1,
10.20 AM -10.50 AM |
Cynthia J. Burrows, University of Utah, , USA
Lessons from DNA Damage Applied to siRNA |
IL -2,
10.50 AM-11.20 AM |
Aloysius Siriwardena,, Université de Picardie Jules Verne, Amiens, France
Synthetic tools that modulate the action glycan metabolising enzymes: the simpler the better ? |
Tea: 11.20 AM-11.40 AM
Parallel Session-III (HALL A)
Chairpersons: Prof. Jyoti Chattopadhyaya and Dr. Mukund Chorghade
IL-3
11.40 AM-12.10 PM |
Asit K. Chakraborti,
National Institute of Pharmaceutical Education and Research (NIPER), S. A. S. Nagar, Punjab – 160062, India
Sustainable Development: An Exploration to the Wonderland of Ionic Liquids |
IL-4
12.10 PM-12.40 PM |
Leena Otsomaa, Orion Corporation, Orion Pharma, Finland
Challenges of Medicinal Chemists |
IL-5
12.50 PM -1.20 PM |
Sreeni Devidas, GVK BioSciences Pvt.Ltd., Hyderabad, India.
Drug Discovery: Is reliance increasing on India and are we prepared for the challenges? |
Parallel Session-IV (HALL B)
Chairpersons: Prof. Graham B. Jones and Dr. Sham Nikam
IL-6
11.40 AM-12.10 PM |
Andrea Vasella, ETH Zurich, Zurich, Switzerland
A New Type of Oligonucleotide Analogues |
IL-7
12.10 PM-12.40 PM |
Prof.V.S.Parmar , Delhi University ,Delhi
Biocatalytic Synthesis of Pharmaceutically Important Nanomaterials |
IL-8
12.40 PM -1.10 PM |
S. M. S. Chauhan, Delhi University , Delhi
Supramolecular Capsules from Functional Porphyrins and Related Macrocycles |
Lunch 1.20 PM - 2.20 PM
Parallel Session-V (HALL A)
Chairpersons: Dr. K.C. Gupta and Dr. Sudhir K. Singh
IL-9
2.20 PM-2.50 PM |
Graham B. Jones, Department of Chemistry & Chemical Biology, Northeastern University, Boston, MA
Natural Product Inspired Probes of DNA and RNA Microenvironments |
IL-10
2.50 PM-3.20 PM |
Sham Nikam – Nycomed, Germany
Optimization of chemical leads in multi-target strategies |
IL-11
3.20 PM-3.50 PM |
David Haydon, Prolysis Ltd. UK
Discovery and Development of Novel Antibacterials: Antibacterial inhibitors of the essential cell division protein FtsZ |
IL-12
3.50 PM -4.10 PM |
Barbara Zajc, The City College and The City University of New York
Modular assembly of fluoroorganics using julia olefination |
IL-13
4.10 PM -4.30 PM |
Anil Kumar, BITS, PILANI, Raj.
Design and Synthesis of Src Tyrosine Kinase Inhibitors as Therapeutic Agents |
Tea 4.30 PM -4.50 PM
Parallel Session-VI (HALL A)
Chairpersons: Prof. Barbara Zajc and Prof Mahesh K. Lakshman
O-1
4.50 PM-5.00 PM |
Palwinder Singh, Department of Chemistry, Guru Nanak Dev University, Amritsar
Studies of interactions of acridone derivatives with P-gp, ATP and Mg2+ - Search for MDR modulators led to the identification of an anti-candidasis agent |
O-2
5.00 PM-5.10 PM |
Mona Semalty, H.N.B. Garhwal University, Srinagar (Garhwal)
Development of formulations of root extract of Urtica dioica for hair growth promotion and identification of responsible bioactive constituents |
O-3
5.10 PM-5.20 PM |
Akhilesh Kumar Verma,University of Delhi, Delhi
Copper-Catalyzed Regioselective Tandem Synthesis of Indolo, Pyrrolo [2,1-a]isoquinolines and Indolo[2,1-f][1,6]Naphthyridines by the Preferential Addition of N-Heterocycles on ortho-haloalkynes followed by Intramolecular C-2 Arylation |
O-4
5.20 PM-5.30 PM |
M. Bansal , Institute of Medical Sciences, Banaras Hindu University, Varanasi
An assessment of safflower (Carthamus tinctorius) seed extract in the treatment of periodontal osseous defects in humans: A pilot study |
O-5
5.30P M-5.40 PM |
Vaibhav P. Mehta, Katholieke Universiteit Leuven, Heverlee, Leuven, BELGIUM.
Transition metal-catalyzed desulfitative c-c bond forming reactions of 2-(1h)-pyrazinones |
O-6
5.40 PM-5.50 PM |
Neeloo Singh, Central Drug Research Institute, Lucknow
Target-to-Drug Discovery for Novel Leishmaniacidals |
O-7
5.50 PM-6.00 PM |
Pannuru Venkatesu , Department of Chemistry, University of Delhi, Delhi , India
Effects of Osmolytes or Denaturants on α-Chymotrypsin Activity and the Folding/Unfolding Transition States |
Parallel Session- VII (HALL B)
Chairpersons: Prof. Manas Chakrabarty and Dr. Keshav Deo
IL-14
2.20 PM -2.50 PM |
J. Senn-Bilfinger, Nycomed GmbH & University Suttgart, Germany
Analogue – based Design of Gastric Acid Anti-secretory Agents.
Past and Present |
IL-15
2.50 PM-3.20 PM |
Veena Agarwal – Nicholas Piramal, Mumbai
Innovative Approaches for Discovery and Development of Therapeutics
in Oncology and Metabolic Disorders |
IL-16
3.20 PM-3.50 PM |
Ashvani Singh – Vertex San Diago,USA
Cystic Fibrosis Drug Discovery |
IL-17
3.50 PM - 4.10 PM |
M. S. Shingare, Dr. Babasaheb Ambedkar Marathwada University, Aurangabad, India
Quinoline based various antimicrobials |
IL-18
4.10 PM – 4.30 PM |
Dalip Kumar - Chemistry Group, Birla Institute of Technology and Science, Pilani India
Design and Synthesis of Novel Bioactive Heterocycles as Potential Anticancer Agents
|
Tea 4.30 PM -4.50 PM
Parallel Session-VIII (HALL B)
Chairpersons: Dr. S. B. Katti and Dr. Leena Otsomaa
IL-19
4.50 PM – 5.10 PM |
Abhijit Roychowdhury,Piramal Life Sciences, Mumbai , India
Small molecule mTOR inhibitors as anti-cancer agents: Is selectivity an issue? |
O-8
5.10 PM – 5.20 PM |
Ram Sagar, University of Oxford, Oxford UK.
Synthesis and in-planta activity of caged/phosphotriester precursors of trehalose-6-phosphate (T6P |
O-9
5.20 PM-5.30 PM |
Islam Khan, Kuwait University, Kuwait
Curcumin ameliorates experimental colitis: Singnal transduction through TLR-4 Receptor and Myd88 |
O-10
5.30 PM - 5.40 PM |
Bandana Bose, Banaras Hindu University, Varanasi-221005, India.
Mg(NO3)2 primed seeds: A better tool for somatic embryogenesis in rice (variety- Swarna) –A first report. |
O-11
5.40 PM - 5.50 PM |
Anjali M. Rahatgaonkar, Institute of Science, Civil Lines, Nagpur 440001, India
Facile polymer supported syntheses of n-pegylated quinoline scaffolds: A convienient drug delivery technique |
O-12
5.50 PM – 6.00 PM |
Okram M. Singh, Department of Chemistry, Manipur University, Canchipur, Imphal
Facile synthesis of novel coumarins under solvent-free conditions and their antioxidant evaluation |
O-13
6.00 PM-6.10 PM |
Meenu Aggarwal, Lingaya’s University, Nachauli , Faridabad
Biological and Toxicological Studies of new derivatives synthesised from the sesquiterpene lactones isolated from medicinal plants |
6.00 PM – 7.30 PM Poster Session -II (Poster Numbers 81-160)
7.30 PM – 8.30 PM Cultural Programme
8.30 PM Dinner
Sunday, January 17-01-2010
SESSION – IX
Chairpersons: Prof. Graham B. Jones and Prof. David Haydon
PL-5
9.30 AM – 10.10 AM |
S. Chandrasekaran, Indian Institute of Science, Bangalore-560012, India
Studies on the Synthesis of Thiosugars as Glycosidase Inhibitors |
PL-6
10.10 AM – 10.50 AM |
Jyoti Chattopadhyaya , Uppsala University, Uppsala, Sweden
The Importance of Being Nucleic Acids – Some Structural and Reactivity Considerations. |
Tea : 10.50 AM - 11.10 AM
Parallel Session X (Hall A)
Chairpersons: Prof. S.Chandrasekaran and Prof. Dr. Andrea Vasella
IL-20
11.10 AM - 11.40 AM |
David St. C. Black, University of New South Wales, Sydney, Australia
The Role of Molecular Activation, in the Generation of New Indole Reactivity |
IL-21
11.40 AM – 12.10 PM |
Nancy B. Jackson, Sandia National Laboratories,Albuquerque,NM
The Role of Safety and Security in Chemical Sustainability |
IL-22
12.10 PM - 12.40 PM |
John C. Amedio Jr, ZIOPHARM Oncology, , U.S.A.
Palifosfamide (ZYMAFOS™):A Novel Molecule for the Treatment of Soft Tissue Sarcoma |
IL-23
12.40 PM – 1.10 PM |
Greg Bisacchi, Infection Chemistry, Astra Zeneca Research, Bostan, USA
The Exploitation of Diverse Lead Generation Paradigms to Identify Novel Antibacterial Agents |
IL-24
1.10 PM – 1.30 PM |
Mohan Prasad, Ranbaxy Research Laboratories, Gurgaon
Process Development & Scale up From a Generics Perspective |
Parallel Session XI Chairpersons Prof. S.P. Singh and Prof. V.K.Tandon
IL-25
11.10 AM - 11.40 AM |
Mukund S. Chorghade,THINQ Pharma, USA
Value Creation and New Opportunities in Medicinal Chemistry, Drug Discovery, Process Development and Project Management of Technology Transfer |
IL-26
11.40 AM – 12.10 PM |
Dr. Michael N. Liebman, Strategic Medicine, Inc. PA 19348,USA |
IL-27
12.10 PM - 12.30 PM |
R. A. Mane, Dr. Babasaheb Ambedkar Marathwada University,Aurangabad
Organic Transformations leading to bioactive molecules accelerated by biocatalysts |
IL-28
12.30 PM - 12.50 PM |
Ashok K. Prasad ,University of Delhi, Delhi
Nucleosides and Nucleic Acids: Present and Future Drugs |
IL-29
12.50 PM - 1.10 PM |
Sanjay Kumar, Piramal Life Sciences, Mumbai , India
Discovery of novel inhibitors targeting HIF-1alpha towards anticancer drug development |
Lunch 1.20 PM – 2.00 PM
Parallel Session –XII (Hall A) Chairpersons: Prof. Nancy B. Jackson and Dr. Rakesh Tuli
IL-30
02.00 PM - 02.30 PM |
Binghe Wang, Department of Chemistry and Center for Biotechnology and Drug Design, Georgia State University, Atlanta, GA 30302-4098, USA
Boronolectins and fluorescent boronolectins as potential research tools and diagnostics |
IL-31
02.30 PM - 3.00 PM |
Mahesh K. Lakshman, The City College and The City University of New York, USA
Phosphonium ion chemistry en route to nucleoside modification |
IL-32
3.00 PM - 03.20 PM |
Bipin Pandey, CMC and NPR Department, Zydus Research Centre, Zydus Cadila, Ahmedabad
Importance of Salts and Polymorphs during Drug Discovery and Development |
IL-33
03.30 PM - 03.50 PM |
Kanchugarakoppal. S. Rangappa, University of Mysore, ,Mysore
Implications of heterocycles as chemotherapeutic agents: drug discovery programme |
IL-34
03.50 PM - 4.10 PM |
Shiv K. Agarwal, Unimark Remedies Ltd, Hindustan Antibiotic Campus, Pune
Anticancer Drugs derived from Natural Products |
O-16
4.10 PM - 4.20P M |
Raman K Sharma,Delhi University Delhi
Exploring Enzyme Substrate Specificity for the Separation of Anomeric Mixture of O-Aryl Nucleosides of Diagnostic Importance |
Parallel Session XIII (Hall B)
Chairpersons: Prof. Tsann-Long Su and and Dr. John C. Amedio
IL-35
02.00 PM - 02.30 PM |
Vinod Bhakuni, Central Drug Research Institute, CSIR, Lucknow 226001, India.
An enzymatically active fibrillar film of bacteriophage-associated hyaluronate lyase (hylp2) |
IL-36
02.30 PM - 3.00 PM |
Dr. Sajan Joseph - Lilly & Comp
BisIndolyl Maleimides and Indolocarbazoles as Cyclin Dependent Kinase Inhibitors |
IL-37
3.00 PM - 03.20 PM |
A.S. Mustafa, Kuwait University, Kuwait
Cell mediated immunity assays identify ESAT6-family of proteins for diagnostic and vaccine relevance using overlapping synthetic peptides corresponding to genomic regions of difference of Mycobacterium tuberculosis |
IL-38
03.20 PM - 03.40 PM |
Anamik Shah
Department of Chemistry,Saurashtra University, Rajkot- 360 005
Design, synthesis and small library generation of benzo pyrans and other& Their in vitro anticancer evaluation |
IL-39
03.40 PM - 4.00 PM |
Vishnu K Tandon, Department of Chemistry,Lucknow University,Lucknow-India
Proliferation and Apoptosis in Cancer Cells: The role of Chromophore |
IL-40
4.00 PM-4.20 PM |
Surat Kumar, Dayalbagh Educational Institute,Dayalbagh, Agra, INDIA
Nucleic Acid Binding of Alkaloids: Fluorescence, Docking and Molecular Modeling Approaches |
SPECIAL SESSION
PL-7
Chairperson: Prof. David Black
4.30 PM - 5.10 PM Prof. Robert H. Grubbs, Nobel laureate,
California Institute of Technology, Pasadena, USA
TEA 5.10 PM - 5.30 PM
Parallel Session XIV (Hall A)
Chairpersons: Dr. Yetendra Kumar and Prof. Anil K. Singh
PL-8
5.30 PM – 6.10 PM |
Ram Vishwakarma,,Indian Institute of Integrative Medicine, Jammu, Chemical biology of GPI molecules |
IL-41
6.10 PM – 6.30 PM |
Parthasarathi Das,Aurigene Discovery Technologies Limited, Hyderabad
Macrolide and Ketolide Antibiotics: Synthetic Studies on Narbonolide |
IL-42
6.30 PM – 6.50 PM |
Arun K. Sinha, Institute of Himalayan Bioresource Technology (CSIR), Palampur
Exploring environmentally benign chemical and biocatalytic routes for bioactive phenolics |
Parallel Session XV (Hall B)
Chairpersons: Dr.Vinod Bhakuni & Dr. S. K.Agarwal
PL-9
5.30 PM – 6.10 PM |
Cemil OGRETIR, Eskişehir Osmangazi University try ,Turkey
Theoretical approaches to drug design case studies on QSAR and QSPR |
IL-44A
6.10 PM-6.40 PM |
Dr. Chafique Hamdouchi - Lilly & Comp |
IL-43
6.40 PM – 7.00 PM |
Rajiv Sharma, Piramal Life Sciences Limited, Mumbai, India
Structure-CYP Inhibition Relationships |
IL-44
7.00 PM – 7.20 PM |
Ian A Cliffe, Ranbaxy,Gurgaon
Use of Virtual Compound Libraries for Chemical Hit Finding |
7.00 PM - 8.30 PM Poster session-III (Poster Nos. 160 onward)
8.30 PM Dinner
Monday 18, January, 2010
SESSION –XVI
Chairpersons: Prof. Virinder S. Parmar and Prof. S.M.S.Chauhan
IL-45
9.30 AM -10.10 AM |
Vinod K. Singh,Indian Institute of Science Education and Research Bhopal
Total Synthesis of Bioactive Natural Products |
IL-46
10.10 AM -10.40 AM |
Anil K. Singh, Indian Institute of Technology, Bombay,Mumbai
Design, synthesis and antiradical activity of novel Vitamin E compounds |
IL-47
10.40 AM -11.10 AM |
Dr. Soumitra Banerjee, Fine Solutions Ltd, Israel
Recent advances in containment technologies for Anti cancer drugs |
11.10 AM-11.40 AM |
Prof.Luis Echegoyen Director, Division of Chemistry, National Science Foundation USA |
IL-48
11.40 AM-12.10 PM |
Vommina V. Sureshbabu, , Bangalore University, Bangalore
Synthesis of Peptides and Peptidomimetics: Isothiocyanates derived N-protected amino acids and their utility in the preparation of thioureidopeptides |
IL-49
12.10 PM - 12.30 PM |
Ramesh C. Gupta,Torrent pharmaceuticals Ltd. Gandhinagar , Gujarat, INDIA
Advanced glycation end products and diabetic complications: An overview. |
IL-50
12.30 PM - 12.50 PM |
Diwan S Rawat,Department of Chemistry, University of Delhi, Delhi-110007, India
Synthesis and Antimalarial Activity Evaluation of Tetraoxanes, Tetraoxane-aminoquinoline/triazine Conjugates |
| 12.50 PM - 1.30 PM |
Award session and Valedictory Session |
| 1.30 PM - 2.00 PM |
Lunch |
| 2.00 PM |
Sightseeing |
|
